In terms of revenue, the global companion diagnostics market was valued at $4883.29 million in 2021 and is estimated to reach $15441.90 million by 2030, growing at a CAGR of 13.29% during the forecast period of 2022 to 2030. GLOBAL COMPANION DIAGNOSTICS MARKET FORECAST 2022-2030 Global Companion Diagnostics Market by Technology (in Situ Hybridization,…
The North America companion diagnostics market is likely to rise at a 13.41% CAGR, acquiring a revenue of $6430.01 million during 2022-2030. Get more insights
[vc_row][vc_column width=”3/4″][vc_message]The Europe companion diagnostics market is estimated to develop with a CAGR of 13.06% during the forecasting period of 2022 to 2030, reaching a revenue share of $3997.91 million by 2030. [/vc_message][vc_row_inner el_class=”an-report-custom-heading” css=”.vc_custom_1505382055404{margin-bottom: 32px !important;}”][vc_column_inner width=”1/6″][vc_single_image image=”7478″][/vc_column_inner][vc_column_inner width=”5/6″][vc_column_text] EUROPE COMPANION DIAGNOSTICS MARKET FORECAST 2022-2030 Europe Companion Diagnostics Market by Technology (in Situ Hybridization,…
The Asia-Pacific companion diagnostics market is evaluated to record at a CAGR of 13.55%, during the forecasting period of 2022-2030. Get a Free Sample Report
The Global Cell-free DNA (cfDNA) testing market is anticipated to grow at a CAGR of 18.52%, during the forecast period of 2018-2026. Request free sample report